Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pseudoephedrine Retail Purchase Uniform 9 Gram Threshold Proposed In Bill

This article was originally published in The Tan Sheet

Executive Summary

Retail purchases of "combination ephedrine products" would be limited to 9 g per transaction by legislation introduced in the Senate to curb the illegal production and distribution of methamphetamines

You may also be interested in...



DoJ Pseudoephedrine Suit Seeks Up To $145.6 Mil. From NBTY

The U.S. Department of Justice's office for the Eastern District of New York is seeking up to $145.6 mil. in fines from dietary supplement manufacturer NBTY in response to recordkeeping and reporting violations the firm allegedly committed with regard to mail order shipments of pseudoephedrine-containing OTCs

DoJ Pseudoephedrine Suit Seeks Up To $145.6 Mil. From NBTY

The U.S. Department of Justice's office for the Eastern District of New York is seeking up to $145.6 mil. in fines from dietary supplement manufacturer NBTY in response to recordkeeping and reporting violations the firm allegedly committed with regard to mail order shipments of pseudoephedrine-containing OTCs

DoJ Pseudoephedrine Suit Seeks Up To $145.6 Mil. From NBTY

The U.S. Department of Justice's office for the Eastern District of New York is seeking up to $145.6 mil. in fines from dietary supplement manufacturer NBTY in response to recordkeeping and reporting violations the firm allegedly committed with regard to mail order shipments of pseudoephedrine-containing OTCs

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094340

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel